Biotechs pursue novel strategies for weight loss drugs; in small study, 'brain decoder' inches toward reading minds

You've probably heard of Ozempic. But a clutch of startups say they'll have even better, or at least less nauseating, drugs for weight loss.

May 1, 2023 Check out STAT+

Sponsored By

Molly Ferguson for STAT STAT+ | Beyond Wegovy and Ozempic: Biotechs vie for piece of red-hot weight loss market with novel strategies Emerging from an investment desert, startups hope their weight loss drugs will have a unique edge, like protecting muscle. By Elaine Chen and Allison DeAngelis Survey: Anti-LGBTQ legislation takes alarming mental-health toll on queer youth One-third of queer youth said their mental health last year was poor "most of the time or always" due to anti-LGBTQ policies and legislation. By Theresa Gaffney STAT+ | Sam Waksal and Jeremy Levin plot 'the turnaround story of the century' Sam Waksal, the storied drug developer, and his longtime friend Jeremy Levin, the CEO of Ovid, plot "the turnaround story of the century." By Damian Garde Keith Srakocic/AP In a small new study, scientists working on an AI 'brain decoder' inch closer than ever to reading minds Researchers have developed a "brain decoder" enabled by GPT-1, an earlier version of the artificial intelligence that underpins ChatGPT. By Brittany Trang STAT+ | Carbon Health blasts a major insurer in rare public dispute over coverage Primary care startup Carbon Health blasted Elevance for paying it less than competitors and for refusing to process out-of-network claims. By Mohana Ravindranath Opinion: The apparent poisoning of schoolgirls is just one part of Iran's health crisis The "chemical attacks" on schoolgirls are just one part of the health threats to people in the Islamic Republic of Iran. By Arghavan Salles Jeff Chiu/AP Expansive investigation into Stanford president's past research will be 'substantially complete' by mid-July The investigation has reviewed "more than 26,000 collected documents" and required "hundreds of hours of meetings and witness interviews." By Jonathan Wosen

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser